CAI
Caris Life Sciences, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.43B
P/E Ratio
—
EPS
$-3.22
Beta
—
52W High
$42.50
52W Low
$16.28
50-Day MA
$20.28
200-Day MA
$27.25
Dividend Yield
—
Profit Margin
-8.39%
Forward P/E
36.36
PEG Ratio
—
About Caris Life Sciences, Inc. Common Stock
CAI International, Inc. is a transportation finance company in the United States, Switzerland, France, Korea, Singapore, Rest of Asia, Rest of Europe, and internationally. The company is headquartered in San Francisco, California.
Fundamentals
| Revenue (TTM) | $812.03M |
| Gross Profit (TTM) | $541.04M |
| EBITDA | $67.73M |
| Operating Margin | 30.20% |
| Return on Equity | -45.40% |
| Return on Assets | 3.84% |
| Revenue/Share (TTM) | $4.86 |
| Book Value | $2.04 |
| Price-to-Book | 9.44 |
| Price-to-Sales (TTM) | 6.68 |
| EV/Revenue | 6.26 |
| EV/EBITDA | 446.40 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 125.40% |
| Shares Outstanding | $282.58M |
| Float | $97.08M |
| % Insiders | 48.58% |
| % Institutions | 51.93% |
Historical Volatility
HV 10-Day
70.46%
HV 20-Day
59.67%
HV 30-Day
58.95%
HV 60-Day
61.44%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($31.91 target)
1
Strong Buy8
Buy1
HoldData last updated: 4/10/2026